Related Experiment Video

Updated: May 27, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Molecular-targeted nanotherapies in cancer: enabling treatment specificity

Elvin Blanco1, Angela Hsiao, Guillermo U Ruiz-Esparza

  • 1Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX 77030, USA.

Molecular Oncology
|November 11, 2011
PubMed

Insights

Nanomedicine enhances chemotherapy by using nanoparticle carriers to improve drug delivery to tumors, overcoming biological barriers and reducing patient side effects. This approach holds promise for clinical translation of novel cancer therapies.

Area of Science:

  • Oncology
  • Nanomedicine
  • Drug Delivery

Background:

  • Chemotherapy is a cornerstone of cancer treatment, evolving towards targeted therapies.
  • Despite advances, targeted agents have shown modest survival benefits due to delivery challenges.
  • Biological barriers impede effective drug delivery to tumors, limiting treatment efficacy.

Purpose of the Study:

  • To review innovative nanoparticle-based platforms for chemotherapy delivery.
  • To highlight strategies for overcoming biological barriers in cancer treatment.
  • To discuss the clinical translation potential of novel chemotherapeutic agents.

Main Methods:

  • Review of current nanomedicine approaches for drug delivery.
  • Summary of nanoparticle carrier systems protecting drugs from degradation.
  • Discussion of multistage drug delivery strategies.

Main Results:

  • Nanoparticle carriers improve drug protection, circulation time, and tumor accumulation.
  • Nanomedicine facilitates the delivery of repositioned drugs and siRNAs.
  • Multistage delivery strategies aim to overcome biological barriers effectively.

Conclusions:

  • Nanoparticle-based platforms show significant potential for clinical translation.
  • Improved drug delivery via nanomedicine can reduce patient morbidity.
  • Innovative strategies are crucial for advancing chemotherapy efficacy.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...